newsfilter
← Latest News
PR Newswire·

Cellect Biotechnology Strengthens IP Portfolio; Receives "Intention to Grant" Patents from European and Israeli Patent Offices

Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of innovative technology which enables the functional selection of stem cells, received...